glp 1 medications pros and cons GLP-1 weight loss have significant side effects Mapping the effectiveness and risks

Retatrutide is just the start of a new generation of multi-agonist treatments aimed at addressing obesity, metabolic disease, and even cardiovascular health ushering in a true metabolic medicine revolution.

To minimise the risk of GI AEs, patients should be advised to reduce portion sizes and to reduce the fat content of their meals

For doses between 30 and 50 units, a 0.5mL syringe works well

Q: How can I start to get prescribed Wegovy or Zepbound

For weight management, NICE technology appraisals TA875 (semaglutide/Wegovy) and TA664 (liraglutide/Saxenda) specify that treatment must be initiated within specialist weight management services, with specific BMI thresholds and time-limited treatment periods

Nie jest lekiem, nie jest suplementem diety i nie jest produktem przeznaczonym do spoycia przez ludzi